October 24, 2016 8:00 PM ET


Company Overview of Sanofi-Aventis U.S. LLC

Key Executives for Sanofi-Aventis U.S. LLC

NameBoard RelationshipsTitleAge
Zan Guerry 50 RelationshipsChairman of Chattem and Chief Executive Officer of Chattem67
Hugh O'Neill No RelationshipsChief Executive Officer of Canada Operations and President of Canada Operations--
Christopher A. Viehbacher 35 RelationshipsChief Executive Officer of Sanofi-Aventis56
Jez Moulding No RelationshipsPresident of North America Pharmaceuticals--
Sol Rajfer No RelationshipsPresident of U S Science and Medical Affairs--
View More Key Executives

Sanofi-Aventis U.S. LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Timothy G. Rothwell 7 RelationshipsEmisphere Technologies, Inc.65
Zan Guerry 50 RelationshipsSanofi-Aventis U.S. LLC67
View All Board Members

Sanofi-Aventis U.S. LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Sanofi-Aventis U.S. LLC CEO Compensation
Industry Average


Rhinomed Limited Announces Resignation of Justine Heath as Chief Financial Officer and Chief Operating Officer
October 23, 2016 10:23 PM ET
Cynapsus Therapeutics Inc. Announces Management Changes
October 21, 2016 9:26 PM ET
Mark L. Thompson to Step Down as Chief Executive Officer and Chairman of Concordia International Corp
October 21, 2016 5:55 PM ET
Dechra Pharmaceuticals plc Announces Executive Changes
October 21, 2016 6:00 AM ET
Scot L. Harper, Vice President of Clinical Operations, to Leave Endocyte, Inc., Effective October 28, 2016
October 20, 2016 8:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanofi-Aventis U.S. LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.